Apogee Therapeutics, Inc. - Common Stock (APGE)

Historical Holders from Q3 2023 to Q3 2025

Symbol
APGE on Nasdaq
CUSIP
03770N101
Type / Class
Equity / Common Stock
Shares outstanding
46.1M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
59.6M
Holdings value
$2.37B
% of all portfolios
0.004%
Grand Portfolio weight change
+0%
Number of holders
171
Number of buys
85
Number of sells
-88
Average Value change %
+0%
Average buys %
+0.002%
Average sells %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Apogee Therapeutics, Inc. - Common Stock (APGE)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 15% $273M 6.91M FMR LLC Jun 30, 2025
Fairmount Funds Management LLC 9.99% $230M 5.78M Peter Evan Harwin Oct 10, 2025
WELLINGTON MANAGEMENT GROUP LLP 10.6% +28.8% $193M $42.7M 4.89M +28.4% Wellington Management Group LLP Jul 31, 2025
RTW INVESTMENTS, LP 6% $86.2M 2.71M RTW Investments, LP Dec 31, 2024
BlackRock, Inc. 5.5% $99.7M 2.52M BlackRock, Inc. Jun 30, 2025
DRIEHAUS CAPITAL MANAGEMENT LLC 4.68% $85.8M 2.16M DRIEHAUS CAPITAL MANAGEMENT LLC Sep 30, 2025

Institutional Holders of Apogee Therapeutics, Inc. - Common Stock (APGE)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 59.6M $2.37B +$56.5M $39.73 171
2025 Q2 57.8M $2.51B -$147M $43.43 180
2025 Q1 61.5M $2.3B +$131M $37.36 165
2024 Q4 57.9M $2.62B +$63.3M $45.30 156
2024 Q3 56.1M $3.29B +$134M $58.74 139
2024 Q2 54.2M $2.13B -$9.27M $39.35 137
2024 Q1 52.9M $3.52B +$773M $66.45 138
2023 Q4 26.5K $740K +$740K $27.94 2
2023 Q3 40.1M $849M +$849M $21.30 72